The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Epidemic Salmonella typhimurium DT 104--a truly international multiresistant clone
Open accessAbstract
Over the last decade, antibiotic resistance and particularly multiple resistance (to four or more drugs) has increased dramatically in salmonellae isolated from infected patients in Western Europe and North America. An important factor in this increase has been the epidemic spread, since 1990, of multiresistant Salmonella typhimurium definitive phage type (DT) 104 with resistance to ampicillin, chloramphenicol, streptomycin, sulphonamides and tetracyclines (ACSSuT resistance type).1 Strains of this phage type/ resistance type combination have become widely distributed in cattle in the UK since the early 1990s,2 and have subsequently been transmitted to humans through the food chain.3 In England and Wales, isolations of multiresistant DT 104 from humans increased from about 200 in 1990 to >4000 in 1996.4 However, over the last two years there has been a significant decline in isolations, with numbers dropping by 48% in 1998, to 2090.5 Antibiotic-susceptible isolates of S. typhimurium DT 104 have been obtained from cases of of human infection in England and Wales since the early 1960s. However, multiresistant DT 104 of resistance type ACSSuT was not identified until the early 1980s, with the first isolations from gulls and exotic birds. With the exception of a small outbreak in Scotland in the mid-1980s, there were no isolations of multiresistant DT 104 from humans until 1989, by which time the strain had begun to be isolated from cattle. Over the next 5 years, multiresistant DT 104 became epidemic in cattle throughout the UK.6 However, in contrast to previous epidemic multiresistant phage types of S. typhimurium, such as DTs 29, 204, 193 and 204c,7–9 which were for the most part confined to cattle, multiresistant DT 104 has also become common in poultry (particularly turkeys), pigs and sheep.2 Human infection with multiresistant DT 104 has been associated with the consumption of chicken, beef, pork sausages and meat paste3 and, to a lesser extent, with occupational contact with infected cattle.10 Although some variants have been identified, the majority of multiresistant DT 104 have a distinctive XbaI-generated macrorestriction fingerprint when studied by pulsed-field gel electrophoresis.11,12 Over the last 4 years, this clone has caused outbreaks of infection in food animals and humans in numerous European countries including the Irish Republic,13 Denmark,14,15 Germany,12,16 Austria,12 France,17 the Czech Republic,18 Italy (A. Caratolli, personal communication) and Sweden (R. Wollin, personal communication). Infections in humans have also been recognized in Trinidad, South Africa, The Netherlands, Northern Ireland, the United Arab Emirates and the Philippines,11,12 and in Israel.19 In 1996 infections with multiresistant DT 104 were recognized in cattle and humans in North America, both in Canada20 and the USA.21–23 In the USA a considerable number of outbreaks have been associated with the consumption of cheese made from raw milk.24–26 Of particular concern has been the resistance of the organism to a wide range of therapeutic antimicrobial agents. Furthermore, in some countries there have been reports of an apparent predilection of the organism to cause serious disease.3,14,15,21,25,26 However, a recent UK study has demonstrated that multiresistant DT 104 appears no more invasive than other common serotypes and phage types in terms of isolations from blood culture in comparison with faecal isolations.4 Genetic analysis has demonstrated that in multiresistant DT 104 of resistance type ACSSuT, the complete spectrum of antibiotic resistance is chromosomally encoded.1 Investigation of a selection of multiresistant strains by PCR demonstrated integron hot spots in two copies as two discrete bands of approximately 1.0 and 1.2 kb. Direct nucleotide sequencing of the individual amplicons indicated that the 1.0 kb gene product was the enzyme ANT (3′′)-1a, responsible for resistance to streptomycin (and also to spectinomycin); the 1.2 kb amplicon contained the gene blaP1, encoding the β-lactamase CARB-2 (PSE-1).11,27 It is particularly noteworthy that all isolates of multiresistant DT 104 of the ACSSuT phenotype have contained the same gene cassettes irrespective of source (food animal or human) or country of origin.11 An indistinguishable β-lactamase has also been identified in France in strains designated as ‘12 atypic’, which probably corresponds to multiresistant DT 104.17 Subsequent studies have demonstrated that the genes for chloramphenicol and tetracycline resistance are grouped between the ampicillin and streptomycin/spectinomycin integrons described above.28 Antibiotic resistance in multiresistant DT 104 of resistance type ACSSuT therefore comprises a sequence of approximately 1.4 kb, containing the ampicillin and streptomycin/ spectinomycin integrons, and intervening plasmid-derived genes coding for resistance to chloramphenicol and tetracyclines. Since 1992 a disturbing feature of infections with multire
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glynn, M. K., Bopp, C., Dewitt, W., Dabney, P., Mokhtar, M., & Angulo, F. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381901 · Cited by 615
Mølbak, K., Baggesen, D. L., Aarestrup, F. M., Ebbesen, J. M., Engberg, J., Frydendahl, K., Gerner-Smidt, P., Petersen, A. M., & Wegener, H. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911043411902 · Cited by 493
Molecular Characterization of an Antibiotic Resistance Gene Cluster of Salmonella typhimurium DT104
Briggs, C. E., & Fratamico, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.846 · Cited by 313
Sandvang, D., Aarestrup, F. M., & Jensen, L. B. (1998) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1998.tb12887.x · Cited by 274
Threlfall, E., Frost, J., Ward, L., & Rowe, B. (1994) · Veterinary Record · doi:10.1136/vr.134.22.577 · Cited by 249
Self-citationRidley, A., & Threlfall, E. J. (1998) · Microbial Drug Resistance · doi:10.1089/mdr.1998.4.113 · Cited by 192
Self-citationSalmonella typhimurium DT104: a virulent and drug-resistant pathogen.
Poppe, C., Smart, N., Khakhria, R., Johnson, W. M., Spika, J. S., & Prescott, J. F. (1998) · Europe PMC (PubMed Central) · Cited by 172
Drug Resistance in Salmonella Typhimurium and its Implications
Anderson, E. S. (1968) · BMJ · doi:10.1136/bmj.3.5614.333 · Cited by 172
Cited by
Food-borne diseases—The challenges of 20 years ago still persist while new ones continue to emerge
Newell, D. G., Koopmans, M., Verhoef, L., Duizer, E., Aidara-Kane, A., Sprong, H., Opsteegh, M., Langelaar, M., Threfall, J., Scheutz, F., et al. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.01.021 · Cited by 1,257
Crump, J. A., Sjölund-Karlsson, M., Gordon, M. A., & Parry, C. M. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-15 · Cited by 1,156
Threlfall, E. J. (2002) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(02)00092-x · Cited by 497
Self-citationWales, A., & Davies, R. (2015) · Antibiotics · doi:10.3390/antibiotics4040567 · Cited by 443
Resistance in bacteria of the food chain: Epidemiology and control strategies
Aarestrup, F. M., Wegener, H. C., & Collignon, P. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.733 · Cited by 406
Metadata
- Authors
- Threlfall, E. J.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-07-01
- Volume
- 46
- Issue
- 1
- Pages
- 7-10
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2128676609
- Cited by
- 317
- References
- 19
- FWCI
- 19.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidemic Salmonella typhimurium DT 104--a truly international multiresistant clone. https://app.cochat.ai/papers/10.1093/jac/46.1.7
- The paper
- Threlfall, E. J. (2000). Epidemic Salmonella typhimurium DT 104--a truly international multiresistant clone. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/46.1.7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.